Location: New York, NY
CIK: 0001727492 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value: $479M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORPORATION | 8,118,592 | $120M | 25.0% | $5.57 | +161.8% | COM NEW | 53635D202 |
| — | VERONA PHARMA PLC | 1,436,878 | $91.23M | 19.0% | $16.60 | — | SPONSORED ADS | 925050106 |
| EXEL | EXELIXIS INC | 1,525,730 | $56.33M | 11.8% | $19.42 | +83.5% | COM | 30161Q104 |
| MLYS | MINERALYS THERAPEUTICS INC | 2,149,667 | $34.14M | 7.1% | $11.97 | -3.9% | COM | 603170101 |
| EOLS | EVOLUS INC | 2,731,154 | $32.86M | 6.9% | $10.65 | +22.8% | COM | 30052C107 |
| — | SAGE THERAPEUTICS INC | 3,052,538 | $24.27M | 5.1% | $5.43 | — | COM | 78667J108 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 3,107,669 | $23.31M | 4.9% | $5.90 | +36.7% | COM | 09058V103 |
| ANIK | ANIKA THERAPEUTICS INC | 1,435,130 | $21.57M | 4.5% | $25.57 | -34.9% | COM | 035255108 |
| AGIO | AGIOS PHARMACEUTICALS INC | 701,280 | $20.55M | 4.3% | $28.21 | +17.6% | COM | 00847X104 |
| RVMD | REVOLUTION MEDICINES INC | 465,000 | $16.44M | 3.4% | $40.59 | 0.0% | COM | 76155X100 |
| — | MERUS N V | 376,954 | $15.87M | 3.3% | $42.06 | — | COM | N5749R100 |
| — | Y-MABS THERAPEUTICS INC | 2,342,609 | $10.38M | 2.2% | $8.13 | — | COM | 984241109 |
| ABVX | ABIVAX SA | 1,269,119 | $7.932M | 1.7% | $6.88 | — | SPONSORED ADS | 00370M103 |
| — | VERRICA PHARMACEUTICALS INC | 8,992,954 | $3.977M | 0.8% | $0.66 | — | COM | 92511W108 |
| RZLT | REZOLUTE INC | 141,309 | $410K | 0.1% | $4.35 | 0.0% | COM NEW | 76200L309 |
| TYRA | TYRA BIOSCIENCES INC | 25,000 | $233K | 0.0% | $12.94 | 0.0% | COM | 90240B106 |